Astrana Health (NASDAQ:ASTH - Get Free Report) released its quarterly earnings results on Thursday, August 7th. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.36 by ($0.17), Zacks reports. The company had revenue of $654.81 million during the quarter, compared to analyst estimates of $639.13 million. Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The company's revenue for the quarter was up 34.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.40 EPS. Astrana Health updated its Q3 2025 guidance to EPS.
Astrana Health Stock Down 0.3%
Astrana Health stock traded down $0.09 during mid-day trading on Thursday, hitting $29.54. The company's stock had a trading volume of 470,990 shares, compared to its average volume of 493,487. The firm's 50 day moving average is $24.79 and its 200 day moving average is $28.97. The company has a market cap of $1.66 billion, a PE ratio of 57.92, a price-to-earnings-growth ratio of 0.74 and a beta of 0.85. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.59 and a quick ratio of 1.59. Astrana Health has a 52-week low of $21.20 and a 52-week high of $63.20.
Institutional Investors Weigh In On Astrana Health
Several hedge funds have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Astrana Health by 46.3% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,710 shares of the company's stock worth $938,000 after acquiring an additional 11,942 shares in the last quarter. Squarepoint Ops LLC lifted its stake in Astrana Health by 475.4% in the 2nd quarter. Squarepoint Ops LLC now owns 95,557 shares of the company's stock worth $2,377,000 after acquiring an additional 78,951 shares in the last quarter. AXA S.A. purchased a new stake in Astrana Health in the 2nd quarter worth about $3,150,000. WINTON GROUP Ltd purchased a new stake in Astrana Health in the 2nd quarter worth about $233,000. Finally, JPMorgan Chase & Co. lifted its stake in Astrana Health by 31.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 92,201 shares of the company's stock worth $2,294,000 after acquiring an additional 22,030 shares in the last quarter. 52.77% of the stock is owned by hedge funds and other institutional investors.
Astrana Health Company Profile
(
Get Free Report)
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
See Also
Before you consider Astrana Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.
While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
